Indication for the administration of tranexamic acid |
All hip fractures |
Contraindications to the administration of tranexamic acid |
Known intolerance |
Severe renal insufficiency (risk of accumulation; see below) |
Congenital or acquired thrombophilia |
Acute arterial and venous thrombosis |
Patient history of arterial/venous thrombosis or ischaemic stroke |
History of stent implantation under dual platelet inhibition |
Known epilepsy |
Pregnancy and lactation |
Hyperfibrinolysis as a result of disseminated intravascular coagulopathy |
Bleeds in the urinary tract |
Patients taking oral contraceptives (increased thrombogenic risk) |
Adjustments in case of renal insufficiency |
Serum creatinine 120 to 249 μmol/l: 10 mg/kg body weight (no further administration for the next 12 h) |
Serum creatinine 250 to 500 μmol/l: 10 mg/kg body weight (no further administration for the next 24 h) |